Literature DB >> 32235085

The novel zoonotic COVID-19 pandemic: An expected global health concern.

Carlo Contini1, Mariachiara Di Nuzzo2, Nicole Barp3, Aurora Bonazza4, Roberto De Giorgio5, Mauro Tognon6, Salvatore Rubino7.   

Abstract

18 years ago, in 2002, the world was astonished by the appearance of Severe Acute Respiratory Syndrome (SARS), supported by a zoonotic coronavirus, called SARS-CoV, from the Guangdong Province of southern China. After about 10 years, in 2012, another similar coronavirus triggered the Middle East Respiratory Syndrome (MERS-CoV) in Saudi Arabia. Both caused severe pneumonia killing 774 and 858 people with 8700 cases of confirmed infection for the former, and 2494 for the latter, causing significant economic losses. 8 years later, despite the MERS outbreak remaining in certain parts of the world, at the end of 2019, a new zoonotic coronavirus (SARS-CoV-2) and responsible of coronavirus Disease (COVID-19), arose from Wuhan, Hubei Province, China. It spread rapidly and to date has killed 3,242 persons with more than 81,000 cases of infection in China and causing over 126,000 global cases and 5,414 deaths in 166 other countries around the world, especially Italy. SARS-CoV-2 would seem to have come from a bat, but the intermediate reservoir continues to be unknown. Nonetheless, as for SARS-CoV and MERS CoV, the Spillover effect linked to animal-human promiscuity, human activities including deforestation, illegal bush-trafficking and bushmeat, cannot be excluded. Recently, however, evidence of inter-human only transmission of SARS-CoV-2 has been accumulated and thus, the outbreak seems to be spreading by human-to-human transmission throughout a large part of the world. Herein we will provide with an update on the main features of COVID-19 and suggest possible solutions how to halt the expansion of this novel pandemic. Copyright (c) 2020 Carlo Contini, Mariachiara Di Nuzzo, Nicole Barp, Aurora Bonazza, Roberto De Giorgio, Mauro Tognon, Salvatore Rubino.

Entities:  

Keywords:  COVID-19; MERS CoV; SARS CoV; SARS-CoV-2; drugs; spillover

Year:  2020        PMID: 32235085     DOI: 10.3855/jidc.12671

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  59 in total

1.  ARIMA models for predicting the end of COVID-19 pandemic and the risk of second rebound.

Authors:  Zohair Malki; El-Sayed Atlam; Ashraf Ewis; Guesh Dagnew; Ahmad Reda Alzighaibi; Ghada ELmarhomy; Mostafa A Elhosseini; Aboul Ella Hassanien; Ibrahim Gad
Journal:  Neural Comput Appl       Date:  2020-10-23       Impact factor: 5.606

2.  Impact of the COVID-19 pandemic on psychological distress and biological rhythm in China's general population: A path analysis model.

Authors:  Yikai Dou; Huanhuan Fan; Xiao Yang; Yue Du; Yu Wang; Min Wang; Zijian Zhang; Xiongwei Qi; Yuling Luo; Ruiqing Luo; Xiaohong Ma
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Living conditions and mental wellness in a changing climate and environment: focus on community voices and perceived environmental and adaptation factors in Greenland.

Authors:  Ulla Timlin; Jón Haukur Ingimundarson; Leneisja Jungsberg; Sofia Kauppila; Joan Nymand Larsen; Tanja Nordström; Johanna Scheer; Peter Schweitzer; Arja Rautio
Journal:  Heliyon       Date:  2021-04-30

4.  No molecular evidence of SARS-CoV-2 infection in companion animals from Veracruz, Mexico.

Authors:  Sokani Sánchez-Montes; Gerardo G Ballados-González; Janete Gamboa-Prieto; Anabel Cruz-Romero; Dora Romero-Salas; Carlos D Pérez-Brígido; María J Austria-Ruíz; Alfredo Guerrero-Reyes; Miguel A Lammoglia-Villagómez; Ireri P Camacho-Peralta; José Á Morales-Narcia; José L Bravo-Ramos; Manuel Barrientos-Villeda; Leopoldo A Blanco-Velasco; Ingeborg Becker
Journal:  Transbound Emerg Dis       Date:  2021-06-02       Impact factor: 4.521

5.  Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome.

Authors:  Kapil G Zirpe; Anand M Tiwari; Sushma K Gurav; Abhijit M Deshmukh; Prasad B Suryawanshi; Prajkta P Wankhede; Upendrakumar S Kapse; Abhaya P Bhoyar; Afroz Z Khan; Ria V Malhotra; Pranoti H Kusalkar; Kaustubh J Chavan; Seema A Naik; Rahul B Bhalke; Ninad N Bhosale; Sonika V Makhija; Venkata N Kuchimanchi; Amol S Jadhav; Kedar R Deshmukh; Gaurav S Kulkarni
Journal:  Indian J Crit Care Med       Date:  2021-05

Review 6.  Airborne Coronaviruses: Observations from Veterinary Experience.

Authors:  Paolo Pozzi; Alessio Soggiu; Luigi Bonizzi; Nati Elkin; Alfonso Zecconi
Journal:  Pathogens       Date:  2021-05-19

7.  AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.

Authors:  Bijon Kumar Sil; Mohd Raeed Jamiruddin; Md Ahsanul Haq; Mohib Ullah Khondoker; Nowshin Jahan; Shahad Saif Khandker; Tamanna Ali; Mumtarin Jannat Oishee; Taku Kaitsuka; Masayasu Mie; Kazuhito Tomizawa; Eiry Kobatake; Mainul Haque; Nihad Adnan
Journal:  Int J Nanomedicine       Date:  2021-07-09

8.  Development and Evaluation of Peptidomimetic Compounds against SARS-CoV-2 Spike Protein: An in silico and in vitro Study.

Authors:  Omid Zarei; Hannah Kleine-Weber; Markus Hoffmann; Maryam Hamzeh-Mivehroud
Journal:  Mol Inform       Date:  2022-02-01       Impact factor: 4.050

Review 9.  Effects of air pollutants on the transmission and severity of respiratory viral infections.

Authors:  José L Domingo; Joaquim Rovira
Journal:  Environ Res       Date:  2020-05-11       Impact factor: 6.498

10.  SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?

Authors:  F Rongioletti
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.